RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

Well, here is a possibility-Cortex offers that phase 2 POC and strong chemistry IP is worth alot more than .20 and the market is not valuing it's technology so, a better gauge of value is a subjective assessment based on more rational valuation of such. I mean it's very realistic, $10 million up front 10 million shares @ a buck, milestones of $5 to 10 million upon completing phase 2's successfully, bigger multiples upon commercial , then royalties by which time we'd be acquired.